Cellectar Biosciences Stock Price History
| CLRB Stock | USD 0.30 0.02 6.25% |
Below is the normalized historical share price chart for Cellectar Biosciences extending back to June 14, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cellectar Biosciences stands at 0.30, as last reported on the 14th of March 2025, with the highest price reaching 0.32 and the lowest price hitting 0.28 during the day.
If you're considering investing in Cellectar Stock, it is important to understand the factors that can impact its price. Cellectar Biosciences appears to be dangerous, given 3 months investment horizon. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of 0.0686, which signifies that the company had a 0.0686 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Cellectar Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Cellectar Biosciences' Risk Adjusted Performance of (0.07), standard deviation of 11.25, and Mean Deviation of 5.74 to double-check if our risk estimates are consistent with your expectations.
At present, Cellectar Biosciences' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 14.8 M, whereas Total Stockholder Equity is projected to grow to (14.4 M). . The current year's Price To Sales Ratio is expected to grow to -1,046. In addition to that, Price Earnings Ratio is expected to decline to -0.26. Cellectar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of November 2005 | 200 Day MA 1.6366 | 50 Day MA 0.2878 | Beta 0.965 |
Cellectar |
Sharpe Ratio = 0.0686
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CLRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.2 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Cellectar Biosciences is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellectar Biosciences by adding it to a well-diversified portfolio.
Cellectar Biosciences Stock Price History Chart
There are several ways to analyze Cellectar Stock price data. The simplest method is using a basic Cellectar candlestick price chart, which shows Cellectar Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 3, 2025 | 0.35 |
| Lowest Price | December 19, 2024 | 0.24 |
Cellectar Biosciences March 14, 2025 Stock Price Synopsis
Various analyses of Cellectar Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cellectar Stock. It can be used to describe the percentage change in the price of Cellectar Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cellectar Stock.| Cellectar Biosciences Price Rate Of Daily Change | 0.94 | |
| Cellectar Biosciences Accumulation Distribution | 1,617,922 | |
| Cellectar Biosciences Price Action Indicator | (0.01) | |
| Cellectar Biosciences Price Daily Balance Of Power | (0.50) |
Cellectar Biosciences March 14, 2025 Stock Price Analysis
Cellectar Stock Price History Data
The price series of Cellectar Biosciences for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 has a statistical range of 1.23 with a coefficient of variation of 79.65. The prices are distributed with arithmetic mean of 0.37. The median price for the last 90 days is 0.29. The company had 1:10 stock split on 22nd of July 2022. Cellectar Biosciences issued dividends on 2018-07-17.| Open | High | Low | Close | Volume | ||
| 03/13/2025 | 0.32 | 0.32 | 0.28 | 0.30 | 12,943,377 | |
| 03/12/2025 | 0.31 | 0.33 | 0.31 | 0.32 | 461,175 | |
| 03/11/2025 | 0.33 | 0.33 | 0.30 | 0.31 | 479,773 | |
| 03/10/2025 | 0.32 | 0.34 | 0.31 | 0.32 | 1,288,592 | |
| 03/07/2025 | 0.31 | 0.32 | 0.31 | 0.32 | 807,221 | |
| 03/06/2025 | 0.30 | 0.32 | 0.30 | 0.31 | 704,505 | |
| 03/05/2025 | 0.29 | 0.31 | 0.29 | 0.30 | 488,197 | |
| 03/04/2025 | 0.28 | 0.29 | 0.27 | 0.28 | 621,266 | |
| 03/03/2025 | 0.30 | 0.31 | 0.27 | 0.28 | 683,873 | |
| 02/28/2025 | 0.29 | 0.29 | 0.27 | 0.29 | 671,740 | |
| 02/27/2025 | 0.29 | 0.30 | 0.28 | 0.29 | 372,687 | |
| 02/26/2025 | 0.28 | 0.29 | 0.28 | 0.29 | 282,167 | |
| 02/25/2025 | 0.28 | 0.31 | 0.28 | 0.28 | 762,722 | |
| 02/24/2025 | 0.31 | 0.32 | 0.29 | 0.29 | 685,722 | |
| 02/21/2025 | 0.34 | 0.34 | 0.31 | 0.31 | 648,437 | |
| 02/20/2025 | 0.34 | 0.34 | 0.32 | 0.33 | 809,367 | |
| 02/19/2025 | 0.33 | 0.35 | 0.32 | 0.33 | 1,226,746 | |
| 02/18/2025 | 0.31 | 0.32 | 0.30 | 0.31 | 1,105,034 | |
| 02/14/2025 | 0.28 | 0.30 | 0.28 | 0.29 | 806,375 | |
| 02/13/2025 | 0.28 | 0.29 | 0.26 | 0.28 | 1,045,026 | |
| 02/12/2025 | 0.29 | 0.30 | 0.27 | 0.29 | 1,138,805 | |
| 02/11/2025 | 0.30 | 0.30 | 0.28 | 0.29 | 1,398,688 | |
| 02/10/2025 | 0.33 | 0.33 | 0.30 | 0.31 | 2,522,620 | |
| 02/07/2025 | 0.29 | 0.32 | 0.29 | 0.30 | 2,710,521 | |
| 02/06/2025 | 0.26 | 0.29 | 0.26 | 0.28 | 2,954,780 | |
| 02/05/2025 | 0.25 | 0.27 | 0.25 | 0.26 | 781,513 | |
| 02/04/2025 | 0.26 | 0.28 | 0.25 | 0.26 | 2,328,666 | |
| 02/03/2025 | 0.25 | 0.27 | 0.25 | 0.26 | 880,746 | |
| 01/31/2025 | 0.25 | 0.26 | 0.25 | 0.25 | 493,595 | |
| 01/30/2025 | 0.24 | 0.25 | 0.23 | 0.25 | 1,330,552 | |
| 01/29/2025 | 0.26 | 0.26 | 0.24 | 0.24 | 916,902 | |
| 01/28/2025 | 0.27 | 0.27 | 0.25 | 0.26 | 391,287 | |
| 01/27/2025 | 0.24 | 0.28 | 0.24 | 0.27 | 2,033,670 | |
| 01/24/2025 | 0.24 | 0.27 | 0.24 | 0.26 | 1,520,832 | |
| 01/23/2025 | 0.24 | 0.25 | 0.24 | 0.24 | 722,948 | |
| 01/22/2025 | 0.25 | 0.26 | 0.25 | 0.25 | 932,929 | |
| 01/21/2025 | 0.25 | 0.25 | 0.23 | 0.25 | 1,402,163 | |
| 01/17/2025 | 0.25 | 0.25 | 0.24 | 0.24 | 960,365 | |
| 01/16/2025 | 0.25 | 0.25 | 0.23 | 0.24 | 2,269,832 | |
| 01/15/2025 | 0.26 | 0.27 | 0.23 | 0.25 | 3,551,247 | |
| 01/14/2025 | 0.28 | 0.29 | 0.25 | 0.28 | 2,042,308 | |
| 01/13/2025 | 0.29 | 0.31 | 0.27 | 0.28 | 21,179,520 | |
| 01/10/2025 | 0.31 | 0.31 | 0.27 | 0.28 | 1,632,712 | |
| 01/08/2025 | 0.33 | 0.33 | 0.29 | 0.31 | 1,523,397 | |
| 01/07/2025 | 0.35 | 0.36 | 0.34 | 0.34 | 577,952 | |
| 01/06/2025 | 0.35 | 0.36 | 0.33 | 0.35 | 1,752,809 | |
| 01/03/2025 | 0.32 | 0.35 | 0.31 | 0.35 | 1,632,196 | |
| 01/02/2025 | 0.31 | 0.33 | 0.30 | 0.32 | 1,502,149 | |
| 12/31/2024 | 0.29 | 0.30 | 0.28 | 0.30 | 1,470,824 | |
| 12/30/2024 | 0.31 | 0.32 | 0.27 | 0.29 | 2,249,174 | |
| 12/27/2024 | 0.31 | 0.33 | 0.29 | 0.31 | 2,655,498 | |
| 12/26/2024 | 0.27 | 0.31 | 0.25 | 0.31 | 6,231,647 | |
| 12/24/2024 | 0.27 | 0.28 | 0.25 | 0.25 | 800,426 | |
| 12/23/2024 | 0.24 | 0.28 | 0.24 | 0.28 | 4,129,443 | |
| 12/20/2024 | 0.24 | 0.25 | 0.23 | 0.24 | 2,193,614 | |
| 12/19/2024 | 0.25 | 0.25 | 0.22 | 0.24 | 2,501,137 | |
| 12/18/2024 | 0.26 | 0.27 | 0.25 | 0.25 | 4,374,920 | |
| 12/17/2024 | 0.25 | 0.28 | 0.24 | 0.26 | 3,496,070 | |
| 12/16/2024 | 0.27 | 0.27 | 0.24 | 0.26 | 5,723,053 | |
| 12/13/2024 | 0.26 | 0.27 | 0.23 | 0.26 | 7,347,101 | |
| 12/12/2024 | 0.30 | 0.31 | 0.25 | 0.26 | 11,913,320 |
About Cellectar Biosciences Stock history
Cellectar Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cellectar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cellectar Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cellectar Biosciences stock prices may prove useful in developing a viable investing in Cellectar Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.1 M | 14.8 M | |
| Net Loss | -25.7 M | -24.5 M |
Cellectar Biosciences Stock Technical Analysis
Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Cellectar Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cellectar Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cellectar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cellectar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | 0.5837 | |||
| Treynor Ratio | (0.72) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cellectar Stock analysis
When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |